Corient IA LLC Buys New Position in Agilent Technologies, Inc. $A

Key Points

• Corient IA LLC has invested approximately $292,000 in Agilent Technologies by acquiring 2,500 shares in the first quarter of the year.
• Agilent Technologies recently reported an earnings per share (EPS) of $1.31, exceeding analysts' expectations and showing a revenue increase of 6.0% year-over-year.
• The company announced a quarterly dividend of $0.248 per share, resulting in a 0.8% dividend yield with a payout ratio of 24.44%.

Corient IA LLC acquired a new stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 2,500 shares of the medical research company's stock, valued at approximately $292,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Sunbelt Securities Inc. lifted its holdings in Agilent Technologies by 640.0% during the fourth quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company's stock valued at $30,000 after purchasing an additional 192 shares in the last quarter. Whipplewood Advisors LLC lifted its holdings in Agilent Technologies by 286.2% during the first quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company's stock valued at $29,000 after purchasing an additional 186 shares in the last quarter. Wood Tarver Financial Group LLC purchased a new position in Agilent Technologies during the fourth quarter valued at $34,000. Stone House Investment Management LLC purchased a new position in Agilent Technologies during the first quarter valued at $30,000. Finally, Opal Wealth Advisors LLC purchased a new position in Agilent Technologies during the first quarter valued at $31,000.

Insiders Place Their Bets

In related news, CEO Padraig Mcdonnell sold 1,508 shares of the business's stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total value of $177,099.52. Following the completion of the transaction, the chief executive officer owned 37,448 shares of the company's stock, valued at approximately $4,397,893.12. The trade was a 3.87% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on A. Leerink Partners increased their target price on shares of Agilent Technologies to $135.00 and gave the company a "buy" rating in a research report on Friday, May 30th. UBS Group cut their price objective on shares of Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating for the company in a research report on Thursday, May 29th. Robert W. Baird lowered their target price on shares of Agilent Technologies from $159.00 to $140.00 and set an "outperform" rating for the company in a research note on Thursday, May 22nd. Barclays raised their price objective on shares of Agilent Technologies from $115.00 to $125.00 and gave the company an "equal weight" rating in a research note on Tuesday, June 24th. Finally, Wall Street Zen raised shares of Agilent Technologies from a "hold" rating to a "buy" rating in a research note on Saturday, June 28th. Seven analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $139.77.

Agilent Technologies Stock Performance

NYSE:A traded up $4.3420 during midday trading on Friday, reaching $121.4920. The stock had a trading volume of 1,278,127 shares, compared to its average volume of 1,943,428. The firm has a fifty day simple moving average of $117.79 and a two-hundred day simple moving average of $117.65. Agilent Technologies, Inc. has a 12-month low of $96.43 and a 12-month high of $153.84. The company has a quick ratio of 1.60, a current ratio of 2.09 and a debt-to-equity ratio of 0.55. The stock has a market cap of $34.51 billion, a P/E ratio of 30.00, a P/E/G ratio of 3.61 and a beta of 1.22.

Agilent Technologies (NYSE:A - Get Free Report) last issued its earnings results on Wednesday, May 28th. The medical research company reported $1.31 EPS for the quarter, topping the consensus estimate of $1.26 by $0.05. Agilent Technologies had a net margin of 17.59% and a return on equity of 25.92%. The company had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.63 billion. During the same period in the previous year, the firm earned $1.22 EPS. The business's revenue was up 6.0% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.540-5.610 EPS. Q3 2025 guidance at 1.350-1.370 EPS. On average, equities analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.